Tweet
<img alt="" height="1" width="1" />
New Cholesterol Drugs Face Doctors Seeking Heart Results
Bloomberg
A new class of cholesterol-lowering medicines from Pfizer Inc. (PFE) and Amgen Inc. (AMGN) may struggle to meet sales projections, as latest treatment guidelines suggest doctors should prescribe only drugs proven to help the heart. Called PCSK9 inhibitors ...
Questions for a New Class of Cholesterol DrugsNew York Times
Amgen and Sanofi Drugs Can Reach US Without Long Studies (2)Businessweek
FDA says new cholesterol drugs may not need outcome studiesReuters
Forbes
all 7 news articles »
More...